Search research articles
Contact Us
Filters
Showing results (131-140 of 282) with videos related to
Page
of 29
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1993
A chromatin folding model that incorporates linker variability generates fibers resembling the native structures
C L Woodcock, S A Grigoryev, R A Horowitz, et al.
Archives of Biochemistry and Biophysics
|
October 3, 2003
The requirement of ammonium or other cations linked with p-cresol sulfate for cross-reactivity with a peptide of myelin basic protein
Patricia L Jackson, Ligong Cao, J Edwin Blalock, et al.
Annals of the Rheumatic Diseases
|
February 1, 1990
Partial purification and characterisation of a synovial fluid inhibitor of osteoblasts
R A Hazelton, R Vedam, P P Masci, et al.
The Journal of Comparative Neurology
|
June 22, 1987
P2, P1, and P0 myelin protein expression in developing rat sixth nerve: a quantitative immunocytochemical study
A F Hahn, J N Whitaker, B Kachar, et al.
The Journal of Trauma
|
February 1, 1974
Hyperlipidemia in experimental disseminated intravascular coagulation
A N Whitaker, I Bunce, B R Knowles, et al.
Journal of Neuroimmunology
|
September 25, 1999
Alanine-substituted peptide ligands differ greatly in their ability to activate autoreactive T-cell subsets specific for the wild-type peptide
D Sun, C Coleclough, R Ji, et al.
Journal of Neuropathology and Experimental Neurology
|
January 1, 1983
Changes in sciatic nerve cathepsin D after ligation or exposure to neurotoxins
J N Whitaker, S P Dodd, Z Sahenk, et al.
The Journal of Infectious Diseases
|
January 1, 1979
Interaction of group A streptococcal lipoteichoic acid with bovine myelin basic protein
I Ofek, J N Whitaker, G L Campbell, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 1, 1995
Outcomes assessment in multiple sclerosis clinical trials: a critical analysis
J N Whitaker, H F McFarland, P Rudge, et al.
Neurology
|
March 1, 1980
Immunosuppressive agents in corticosteroid-refractory childhood dermatomyositis
E Niakan, S E Pitner, J N Whitaker, et al.
Page
of 29
Search research articles
Search
Showing results (131-140 of 282) with videos related to
Sort By:
Page
of 29
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1993
A chromatin folding model that incorporates linker variability generates fibers resembling the native structures
C L Woodcock, S A Grigoryev, R A Horowitz, et al.
Archives of Biochemistry and Biophysics
|
October 3, 2003
The requirement of ammonium or other cations linked with p-cresol sulfate for cross-reactivity with a peptide of myelin basic protein
Patricia L Jackson, Ligong Cao, J Edwin Blalock, et al.
Annals of the Rheumatic Diseases
|
February 1, 1990
Partial purification and characterisation of a synovial fluid inhibitor of osteoblasts
R A Hazelton, R Vedam, P P Masci, et al.
The Journal of Comparative Neurology
|
June 22, 1987
P2, P1, and P0 myelin protein expression in developing rat sixth nerve: a quantitative immunocytochemical study
A F Hahn, J N Whitaker, B Kachar, et al.
The Journal of Trauma
|
February 1, 1974
Hyperlipidemia in experimental disseminated intravascular coagulation
A N Whitaker, I Bunce, B R Knowles, et al.
Journal of Neuroimmunology
|
September 25, 1999
Alanine-substituted peptide ligands differ greatly in their ability to activate autoreactive T-cell subsets specific for the wild-type peptide
D Sun, C Coleclough, R Ji, et al.
Journal of Neuropathology and Experimental Neurology
|
January 1, 1983
Changes in sciatic nerve cathepsin D after ligation or exposure to neurotoxins
J N Whitaker, S P Dodd, Z Sahenk, et al.
The Journal of Infectious Diseases
|
January 1, 1979
Interaction of group A streptococcal lipoteichoic acid with bovine myelin basic protein
I Ofek, J N Whitaker, G L Campbell, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 1, 1995
Outcomes assessment in multiple sclerosis clinical trials: a critical analysis
J N Whitaker, H F McFarland, P Rudge, et al.
Neurology
|
March 1, 1980
Immunosuppressive agents in corticosteroid-refractory childhood dermatomyositis
E Niakan, S E Pitner, J N Whitaker, et al.
Page
of 29